Cargando…
Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
Anti-transcriptional intermediary factor 1γ (anti-TIF1γ) antibody-positive dermatomyositis (DM) is strongly associated with cancer, although the mechanism of action is still unclear. We herein describe the first known case of an 80-year-old woman diagnosed with TIF1γ-positive primary pulmonary lymph...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662058/ https://www.ncbi.nlm.nih.gov/pubmed/32581161 http://dx.doi.org/10.2169/internalmedicine.4702-20 |
_version_ | 1783609320268627968 |
---|---|
author | Nakanishi, Yu Yamaguchi, Kakuhiro Yoshida, Yusuke Sakamoto, Shinjiro Horimasu, Yasushi Masuda, Takeshi Nakashima, Taku Miyamoto, Shintarou Iwamoto, Hiroshi Hirata, Shintaro Fujitaka, Kazunori Hamada, Hironobu Sugiyama, Eiji Hattori, Noboru |
author_facet | Nakanishi, Yu Yamaguchi, Kakuhiro Yoshida, Yusuke Sakamoto, Shinjiro Horimasu, Yasushi Masuda, Takeshi Nakashima, Taku Miyamoto, Shintarou Iwamoto, Hiroshi Hirata, Shintaro Fujitaka, Kazunori Hamada, Hironobu Sugiyama, Eiji Hattori, Noboru |
author_sort | Nakanishi, Yu |
collection | PubMed |
description | Anti-transcriptional intermediary factor 1γ (anti-TIF1γ) antibody-positive dermatomyositis (DM) is strongly associated with cancer, although the mechanism of action is still unclear. We herein describe the first known case of an 80-year-old woman diagnosed with TIF1γ-positive primary pulmonary lymphoepithelioma-like carcinoma (LELC) coexisting with anti-TIF1γ antibody-positive DM. The diagnosis of LELC can only be made by a surgical lung biopsy, and not by a computed tomography-guided biopsy, because of heavy lymphocytic infiltration. This instructive case reaffirmed the importance of active screening for malignancy in patients with anti-TIF1γ antibody-positive DM. Interestingly, the results also suggested that the strong relationship which exists between anti-TIF1γ antibody-positive DM and cancer is potentially caused by tumor-derived TIF1γ. |
format | Online Article Text |
id | pubmed-7662058 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-76620582020-11-25 Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis Nakanishi, Yu Yamaguchi, Kakuhiro Yoshida, Yusuke Sakamoto, Shinjiro Horimasu, Yasushi Masuda, Takeshi Nakashima, Taku Miyamoto, Shintarou Iwamoto, Hiroshi Hirata, Shintaro Fujitaka, Kazunori Hamada, Hironobu Sugiyama, Eiji Hattori, Noboru Intern Med Case Report Anti-transcriptional intermediary factor 1γ (anti-TIF1γ) antibody-positive dermatomyositis (DM) is strongly associated with cancer, although the mechanism of action is still unclear. We herein describe the first known case of an 80-year-old woman diagnosed with TIF1γ-positive primary pulmonary lymphoepithelioma-like carcinoma (LELC) coexisting with anti-TIF1γ antibody-positive DM. The diagnosis of LELC can only be made by a surgical lung biopsy, and not by a computed tomography-guided biopsy, because of heavy lymphocytic infiltration. This instructive case reaffirmed the importance of active screening for malignancy in patients with anti-TIF1γ antibody-positive DM. Interestingly, the results also suggested that the strong relationship which exists between anti-TIF1γ antibody-positive DM and cancer is potentially caused by tumor-derived TIF1γ. The Japanese Society of Internal Medicine 2020-06-23 2020-10-15 /pmc/articles/PMC7662058/ /pubmed/32581161 http://dx.doi.org/10.2169/internalmedicine.4702-20 Text en Copyright © 2020 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Nakanishi, Yu Yamaguchi, Kakuhiro Yoshida, Yusuke Sakamoto, Shinjiro Horimasu, Yasushi Masuda, Takeshi Nakashima, Taku Miyamoto, Shintarou Iwamoto, Hiroshi Hirata, Shintaro Fujitaka, Kazunori Hamada, Hironobu Sugiyama, Eiji Hattori, Noboru Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis |
title | Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis |
title_full | Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis |
title_fullStr | Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis |
title_full_unstemmed | Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis |
title_short | Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis |
title_sort | coexisting tif1γ-positive primary pulmonary lymphoepithelioma-like carcinoma and anti-tif1γ antibody-positive dermatomyositis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662058/ https://www.ncbi.nlm.nih.gov/pubmed/32581161 http://dx.doi.org/10.2169/internalmedicine.4702-20 |
work_keys_str_mv | AT nakanishiyu coexistingtif1gpositiveprimarypulmonarylymphoepitheliomalikecarcinomaandantitif1gantibodypositivedermatomyositis AT yamaguchikakuhiro coexistingtif1gpositiveprimarypulmonarylymphoepitheliomalikecarcinomaandantitif1gantibodypositivedermatomyositis AT yoshidayusuke coexistingtif1gpositiveprimarypulmonarylymphoepitheliomalikecarcinomaandantitif1gantibodypositivedermatomyositis AT sakamotoshinjiro coexistingtif1gpositiveprimarypulmonarylymphoepitheliomalikecarcinomaandantitif1gantibodypositivedermatomyositis AT horimasuyasushi coexistingtif1gpositiveprimarypulmonarylymphoepitheliomalikecarcinomaandantitif1gantibodypositivedermatomyositis AT masudatakeshi coexistingtif1gpositiveprimarypulmonarylymphoepitheliomalikecarcinomaandantitif1gantibodypositivedermatomyositis AT nakashimataku coexistingtif1gpositiveprimarypulmonarylymphoepitheliomalikecarcinomaandantitif1gantibodypositivedermatomyositis AT miyamotoshintarou coexistingtif1gpositiveprimarypulmonarylymphoepitheliomalikecarcinomaandantitif1gantibodypositivedermatomyositis AT iwamotohiroshi coexistingtif1gpositiveprimarypulmonarylymphoepitheliomalikecarcinomaandantitif1gantibodypositivedermatomyositis AT hiratashintaro coexistingtif1gpositiveprimarypulmonarylymphoepitheliomalikecarcinomaandantitif1gantibodypositivedermatomyositis AT fujitakakazunori coexistingtif1gpositiveprimarypulmonarylymphoepitheliomalikecarcinomaandantitif1gantibodypositivedermatomyositis AT hamadahironobu coexistingtif1gpositiveprimarypulmonarylymphoepitheliomalikecarcinomaandantitif1gantibodypositivedermatomyositis AT sugiyamaeiji coexistingtif1gpositiveprimarypulmonarylymphoepitheliomalikecarcinomaandantitif1gantibodypositivedermatomyositis AT hattorinoboru coexistingtif1gpositiveprimarypulmonarylymphoepitheliomalikecarcinomaandantitif1gantibodypositivedermatomyositis |